Literature DB >> 9065130

A pilot study of intravenous ondansetron for hyperemesis gravidarum.

C A Sullivan1, C A Johnson, H Roach, R W Martin, D K Stewart, J C Morrison.   

Abstract

OBJECTIVE: We attempted to determine whether the antiemetic ondansetron would be more effective than promethazine in treating hyperemesis gravidarum. STUDY
DESIGN: Patients with hyperemesis gravidarum who required hospital admission were randomized to receive either intravenous ondansetron (n = 15) or intravenous promethazine (n = 15) in a double-blind manner. Severity of disease was determined by electrolyte status, weight loss, ketonuria, and prior use of outpatient antiemetics. Outcome variables included degree of nausea, weight gain during treatment, days of hospitalization, and number of medication doses.
RESULTS: In this preliminary investigation ondansetron offered no advantage when compared with promethazine in the relief of nausea, weight gain, days of hospitalization (4.5 +/- 2.3 vs 4.5 +/- 1.5), and total doses of medication per hospitalization (2.1 +/- 1.2 vs 1.9 +/- 1.3).
CONCLUSION: This preliminary trial of ondansetron demonstrated no benefit over promethazine in patients hospitalized for hyperemesis gravidarum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9065130     DOI: 10.1016/s0002-9378(96)70607-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Pregnancy-Related Liver Diseases.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Miscellaneous pharmaceutical agents in interventional radiology.

Authors:  Jason Oppenheimer; Charles E Ray; Kimi L Kondo
Journal:  Semin Intervent Radiol       Date:  2010-12       Impact factor: 1.513

Review 3.  Hyperemesis gravidarum: current concepts and management.

Authors:  N K Kuşcu; F Koyuncu
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

Review 4.  Nausea and vomiting of pregnancy.

Authors:  Noel M Lee; Sumona Saha
Journal:  Gastroenterol Clin North Am       Date:  2011-06       Impact factor: 3.806

Review 5.  Nausea and vomiting in early pregnancy.

Authors:  Mario Festin
Journal:  BMJ Clin Evid       Date:  2009-06-03

Review 6.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

7.  Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists.

Authors:  Sophie E McGrath; Alistair Ring
Journal:  Ther Adv Med Oncol       Date:  2011-03       Impact factor: 8.168

8.  Placental transfer of ondansetron during early human pregnancy.

Authors:  Shing-Shun N Siu; Matthew T V Chan; Tze-Kin Lau
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 9.  Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken?

Authors:  C Nelson-Piercy
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 10.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.